Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Scaling Science and Technology Successfully: Insights from the BioWednesday at The Press, Foxton

On 10 September 2025, leaders from across the life sciences industry came together for a One Nucleus BioWednesday Breakfast Session, generously hosted by Mission Street at The Press in Foxton alongside Bidwells.

The session explored what it takes for science and technology companies, particularly spin-outs and early-stage ventures, to grow and scale effectively in the UK.

The panel was moderated by Sue Foxley (Bidwells) and comprised:

London Bio-Innovation Week: 1-5 December 2025: The Next Generation of Conference Collaboration

by Tony Jones, CEO, One Nucleus

Collaboration is Key

Whilst the four events detailed below remain fully independent, they offer a valuable co-location in one city of over 1000 collective event attendees active in basic or translational research and the business of collaboration and investment in bio-innovation.

Manchester Rare Disease Showcase

Join Beacon for Rare Diseases and the rare disease community at the Manchester Rare Disease Showcase 2025!

26 Nov 2025 | Bridgewater Hall, Manchester

Through talks, panels, and discussions, explore pressing themes, such as:

· The relationship between health inequalities and rare diseases

· Innovations in research and drug development for children and young people

· The power of patient advocacy in creating societal change

· The UK Rare Disease Framework and the impact of the NHS 10-year plan

Coulter Partners appoints Sabine Moravi as Associate Partner

LONDON, UK and BASEL, Switzerland - September 25, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, announces the appointment of Sabine Moravi as an Associate Partner. This strategic hire marks a significant step in the firm’s expansion within the Swiss market and the broader DACH region.

Co-development Agreement with US Insulin Pump Device Company for AT278 and Sale of Royalty and Technology Access Fees for up to $11 million

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

Arecor Therapeutics plc
(“Arecor” or the “Company”)

Co-development Agreement with US Insulin Pump Device Company for AT278 and Sale of Royalty and Technology Access Fees for up to $11 million

Subscribe to